s-309309
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jan 4, 2022 (NCT05247970)
Timeline
Indications
Mechanism of action
- 2-acylglycerol O-acyltransferase 2INHIBITOR
MOGAT2 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06106334 | Phase 1 | Nov 15, 2023 | Shionogi |
| NCT05925114 | Phase 2 | Jun 21, 2023 | Shionogi |
| NCT05247970 | Phase 1 | Jan 4, 2022 | Shionogi |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Shionogi | For profit | 3 | 3 | 2 | 2022 |
1 organizations
Page 1 / 1